Seroconversion against SU5 derived synthetic peptides in sheep experimentally infected with different SRLV genotypes by Carrozza, M. L. et al.
 
 
This Accepted Author Manuscript (AAM) is copyrighted and published by Elsevier. It is posted here by 
agreement between Elsevier and the University of Turin. Changes resulting from the publishing process 
- such as editing, corrections, structural formatting, and other quality control mechanisms - may not be 
reflected in this version of the text. The definitive version of the text was subsequently published in  
 
Seroconversion against SU5 derived synthetic peptides in sheep experimentally infected with different 
SRLV genotypes 
Veterinary Microbiology 137 (2009) 369–374 
doi:10.1016/j.vetmic.2009.01.032 
 
You may download, copy and otherwise use the AAM for non-commercial purposes provided that your 
license is limited by the following restrictions: 
 
(1) You may use this AAM for non-commercial purposes only under the terms of the CC-BY-NC-ND 
license.  
(2) The integrity of the work and identification of the author, copyright owner, and publisher must be 
preserved in any copy.  
(3) You must attribute this AAM in the following format: Creative Commons BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/4.0/deed.en), doi:10.1016/j.vetmic.2009.01.032 
	  
	   	  
Seroconversion	  against	  SU5	  derived	  synthetic	  peptides	  in	  sheep	  experimentally	  infected	  with	  different	  
SRLV	  genotypes	  
	  M.L.	  Carrozza	  a,	  M.	  Mazzei	  b*,	  	  	  	  D.	  Lacerenza	  c,	  L.	  Del	  Chiaro	  b,	  M.	  Giammarioli	  d,	  C.	  Marini	  d,	  D.	  Rutili	  d,	  
S.	  Rosati	  c,	  F.	  Tolari	  b	  
*	  Corresponding	  author.	  Tel.:	  +39	  050	  2216964;	  fax:	  +39	  050	  2216941.	  
	  
a	  Scuola	  Normale	  Superiore,	  56126,	  Pisa,	  Italy	  
b	  Dipartimento	  di	  Patologia	  Animale,	  Profilassi	  ed	  Igiene	  degli	  Alimenti,	  Facolta`	  di	  Medicina	  Veterinaria,	  56124,	  Pisa,	  Italy	  
c	  Dipartimento	  di	  Produzioni	  Animali,	  Epidemiologia	  ed	  Ecologia,	  Facolta`	  di	  Medicina	  Veterinaria,	  10095,	  Grugliasco,	  Torino,	  Italy	  
d	  Istituto	  Zooprofilattico	  Sperimentale	  dell’Umbria	  e	  delle	  Marche,	  06126,	  Perugia,	  Italy	  
Abstract	  
Synthetic	  peptides	  were	  generated,	  corresponding	  to	  SU5	  domain	  of	  envelope	  glycoprotein	  of	  Italian	  SRLV	  
isolates	   It-­‐561	   and	   It-­‐Pi1,	   belonging	   respectively	   to	   MVV-­‐	   and	   CAEV-­‐like	   genotypes.	   The	   peptides,	  
encompassing	   an	  N-­‐terminal	   variable	   and	   a	  C-­‐terminal	   conserved	   antibody-­‐binding	   site,	  were	  used	   in	   an	  
ELISA	   assay	   to	   analyse	   the	   sera	   of	   two	   groups	   of	   sheep	   experimentally	   infected	  with	   these	   isolates.	   The	  
kinetics	   and	   specificity	   of	   the	   humoral	   response	   to	   the	   homologous	   and	   heterologous	   antigen	   and	   the	  
affinity	   maturation	   of	   the	   sera	   were	   evaluated.	   Seroconversion	   occurred	   between	   week	   3	   and	   8.	   The	  
response	  to	  SU5	  antigen	  was	  mostly	  type-­‐specific.	  The	  few	  broadly	  reacting	  sera	  may	  reflect	  the	  production	  
of	   antibodies	   directed	   to	   the	   SU5	   constant	   antibody-­‐binding	   site.	   All	   sera	   underwent	   with	   time	   avidity	  
maturation,	  resulting	  in	  the	  appearance	  of	  high	  affinity	  antibodies.	  This	  study	  suggests	  constant	  monitoring	  
of	  the	  circulating	  viral	  variants	  to	  develop	  a	  panel	  of	  diagnostic	  peptides	  representative	  of	  local	  genotypes.	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1.	  Introduction	  
Maedi	  Visna	  Virus	  (MVV)	  and	  Caprine	  Arthritis	  Encephalitis	  Virus	  (CAEV)	  are	  non-­‐oncogenic	  lentiviruses	  of	  
the	   Retroviridae	   family,	   presently	   referred	   to	   as	   Small	   Ruminant	   Lentiviruses	   (SRLVs)	   (Zanoni,	   1998).	   A	  
recent	  phylogenetic	  classification	  of	  these	  viruses	  defines	  two	  main	  groups,	  A	  and	  B,	  including	  respectively	  
MVV-­‐like	  and	  CAEV-­‐like	  genotypes	  (Shah	  et	  al.,	  2004).	  SRLV	   infections	  occur	  almost	  worldwide	  and	  cause	  
relevant	   economic	   losses.	   Therapy	   and	   effective	   vaccine	   are	   not	   yet	   available	   (Gonzalez	   et	   al.,	   2005,	  
Petursson	  et	  al.,	  2005,	  Torsteinsdottir	  et	  al.,	  2007,	  Niesalla	  et	  al.,	  2009	  and	  Reina	  et	  al.,	  2008),	   therefore	  
eradication	  and	  prevention	  of	  the	   infection	   largely	  depend	  on	  early,	  efficient	  and	  correct	   identification	  of	  
infected	   animals	   (de	   Andrés	   et	   al.,	   2005).	   This	   is	   routinely	   done	   by	   serological	   analysis,	   the	   ELISA	   assay	  
being	  the	  most	  sensitive	  and	  suitable	  technique	  both	  for	  large-­‐scale	  screening	  and	  individual	  examination.	  
Several	  ELISA	  protocols	  have	  been	  developed	  so	  far,	  mostly	  based	  on	  antigens	  from	  a	  single	  viral	  strain.	  The	  
specificity	  of	  these	  assays	  is	  generally	  high,	  but	  the	  sensitivity	  shows	  extensive	  variability	  (de	  Andrés	  et	  al.,	  
2005)	  due	  to	  antigenic	  heterogeneity	  of	  SRLVs.	  Recent	  analysis	  of	  two	  Italian	  SRLV	  isolates,	  MVV-­‐like	  It-­‐561	  
and	   CAEV-­‐like	   It-­‐Pi1,	   demonstrated	   that	   gag-­‐encoded	   capsid	   (CA)	   and	   matrix	   (MA)	   proteins	   carry	   type-­‐
specific	   epitopes	   and	   most	   sheep	   and	   goat	   sera	   reacted	   to	   these	   antigens	   in	   a	   type-­‐specific	   manner,	  
irrespective	  of	  the	  species	  of	  origin	  (Grego	  et	  al.,	  2002	  and	  Grego	  et	  al.,	  2005).	  Furthermore,	  homologous	  
CA-­‐MA	  fusion	  protein	  was	  able	  to	  detect	  seroconversion	  at	  an	  earlier	  stage	  compared	  to	  the	  heterologous	  
protein	  (Lacerenza	  et	  al.,	  2006).	  The	  present	  study	  extends	  the	  analysis	  of	  the	  humoral	  response	  induced	  by	  
It-­‐561	  and	  It-­‐Pi1	  to	  SU5,	  one	  of	  the	  major	  epitopes	  of	  the	  envelope	  (Env)	  protein	  (Bertoni	  et	  al.,	  2000	  and	  
Valas	   et	   al.,	   2000).	   Two	   SU5	   synthetic	   peptides	   were	   generated,	   corresponding	   to	   It-­‐561	   and	   It-­‐Pi1	  
sequences.	   The	   peptides	  were	   used	   as	   antigens	   to	   assay	   sera	   from	   two	   groups	   of	   sheep	   experimentally	  
infected	  with	  these	  viruses,	   in	  order	  to	  investigate	  the	  kinetics	  and	  specificity	  of	  the	  humoral	  response	  to	  
the	  homologous	  and	  heterologous	  antigen.	  
2.	  Materials	  and	  methods	  
2.1.	  Viral	  strains	  and	  experimental	  infection	  
SRLV	  strains	  It-­‐561	  (genotype	  A)	  and	  It-­‐Pi1	  (genotype	  B)	  (Grego	  et	  al.,	  2002)	  were	  used	  in	  the	  present	  study.	  
Infection	   of	   sheep	   with	   these	   strains	   has	   been	   described	   by	   Lacerenza	   et	   al.	   (2006).	   Detection	   of	   viral	  
sequences	   in	  blood	  of	  experimental	   sheep	  was	  done	  by	  LTR	  PCR	   (	  Extramiana	  et	  al.,	  2002)	  and	  Pol	  PCR	   (	  
Grego	  et	  al.,	  2002).	  
2.2.	  Cloning,	  sequencing	  and	  sequence	  analysis	  of	  env	  region	  coding	  for	  SU5	  
An	   env	   gene	   fragment	   encompassing	   the	   75	   bp	   “SU5	   total”	   domain	   (	   Mordasini	   et	   al.,	   2006)	   coding	  
sequence	  (nt	  7800–7874)	  was	  amplified	  from	  DNA	  of	  foetal	  ovine	  lung	  fibroblasts	  infected	  respectively	  with	  
It-­‐561	   and	   It-­‐Pi1	   viral	   stocks.	   Primer	   sequences	   (	   Bertoni	   et	   al.,	   2000)	   were	   as	   follows:	   563F:	  
GAYATGRYRGARCAYATGAC	   (nt.	   7272–7291);	   567F:	   GGIACIAAIACWAATTGGAC	   (nt.	   7482–7501);	  
564R:GCYAYATGCTGIACCATGGCATA	  (nt.	  8089–8067).	  The	  nucleotide	  positions	  refer	  to	  the	  CAEV	  sequence	  
published	  by	  Saltarelli	  et	  al.	  (1990)	  (Genbank	  accession	  number	  M33677).	  Amplified	  fragments	  were	  cloned	  
and	  sequenced.	  Genetic	  distances	  were	  calculated	  with	  MEGA	  3	  (	  Kumar	  et	  al.,	  2001)	  and	  used	  to	  construct	  
a	  neighbor-­‐joining	  tree	  with	  the	  Tamura-­‐Nei	  two-­‐parameter	  distance	  option	  (	  Tamura	  and	  Nei,	  1993).	  
2.3.	  Peptide	  ELISA	  
Peptides	   corresponding	   to	   the	   25aa	   “SU5	   total”	   domain	   of	   both	   viruses,	   were	   resuspended	   in	   0.1	   M	  
carbonate	  buffer	  pH	  9.6	  at	  5	  μg/mL.	  ELISA	  plates	  were	  coated	  overnight	  at	  37	  °C	  (50	  μL/well),	  incubated	  for	  
1	  h	  at	  37	  °C	  with	  sera	  diluted	  1/20	  and	  for	  1	  h	  at	  room	  temperature	  with	  a	  1:8000	  dilution	  of	  peroxidase-­‐
labelled	   anti-­‐sheep/goat	   IgG	   monoclonal	   antibody	   (Sigma).	   Optical	   density	   was	   measured	   at	   405	   nm	  
wavelength	  after	  40	  min	  incubation	  with	  ABTS	  (Sigma).	  
2.4.	  Cut-­‐off	  
A	  panel	  of	  sera	  collected	  before	  experimental	  infection	  as	  well	  as	  sequential	  sera	  from	  two	  mock-­‐infected	  
sheep,	  were	   repeatedly	  assayed:	  no	   significant	   interplate	  variation	  of	   the	  absorbance	  was	  observed.	  The	  
cut-­‐off	  was	  calculated	  as	  mean	  absorbance	  of	  negative	  sera	  +	  3	  ×	  S.D.	  Samples	  with	  absorbance	  higher	  than	  
0.3	  were	  considered	  positive	  with	  a	  99%	  confidence	  level.	  A	  serum	  collected	  from	  a	  sheep	  belonging	  to	  a	  
long	  term	  seronegative	  flock	  was	  loaded	  on	  each	  plate.	  
2.5.	  Antibody	  avidity	  measurements	  
The	  avidity	   index	  values	  of	  SU5-­‐specific	  antibodies	  were	  measured	  by	  testing	  the	  stability	  of	  the	  antigen–
antibody	  complexes	  following	  a	  wash	  in	  8	  M	  urea	  (Mordasini	  et	  al.,	  2006).	  Antibodies	  with	  avidity	  indexes	  
<30%	   were	   considered	   to	   be	   of	   low	   affinity;	   those	   with	   values	   between	   30%	   and	   50%	   of	   intermediate	  
avidity	  and	  those	  with	  values	  >50%	  of	  high	  avidity.	  
3.	  Results	  
3.1.	  Cloning	  and	  sequencing	  of	  SU5-­‐encoding	  env	  region	  
The	   env	   sequences	   encompassing	   respectively	   the	   SU5	   domain	   of	   It-­‐561	   and	   It-­‐Pi1	   strains	   (Genbank	  
accession	  numbers:	  It-­‐561:	  EU702487:	  It-­‐Pi1:	  EU709743)	  were	  aligned	  with	  MVV	  and	  CAEV	  prototypic	  env	  
sequences	  of	  worldwide	  origin.	  It-­‐561	  clusters	  with	  representatives	  of	  group	  A	  genotypes	  and	  It-­‐Pi1	  with	  B	  
genotypes	   (	  Fig.	  1a),	   in	  agreement	  with	   the	   results	  of	  a	  phylogenetic	  analysis	  of	  gag	  and	  pol	   sequences	   (	  
Grego	   et	   al.,	   2002	   and	   Grego	   et	   al.,	   2005).	   The	   SU5	   aminoacid	   sequences	   of	   It-­‐561	   and	   It-­‐Pi1	   share	  
homology	  in	  the	  N-­‐terminal	  region,	  which	  is	  well	  conserved	  among	  MVV	  and	  CAEV	  strains,	  and	  diverge	  in	  
the	  C-­‐terminal,	  more	  variable	  portion	  (	  Fig.	  1b).	  
	  
	  	  	  	  Fig.	  1.	  	  
(a)	   Phylogenetic	   analysis	   of	   It-­‐561	   and	   It-­‐Pi1	   env	   fragments	   encompassing	   SU5	   coding	   region.	   The	   neighbor-­‐joining	   tree	  was	   constructed	   using	  
MEGA.	   Bootstrap	   values	   are	   based	  on	   5000	   repetitions.	   The	   accession	  numbers	   refer	   to	   the	   following	   strains:	   AF338227	   (MVV	  K1514,	   Iceland);	  
S51392	  (MVV	  EV1,	  Great	  Britain);	  M31646	  (SA-­‐OMVV,	  South	  Africa);	  EF154467	  (SRLV	  12-­‐5,	  Italy);	  U64439	  (OLV	  85/34,	  USA);	  EF154474	  (SRLV	  12–20,	  
Italy);	  AY900630	  (CAEV	  Gansu,	  China);	  M33677	  (CAEV-­‐Co,	  USA),	  AF322109	  (CAEV	  1GA,	  Norway);	  NC001482	  (FIV).	  (b)	  Alignment	  of	  SU5	  aminoacid	  
sequences	  of	  It-­‐561	  and	  It-­‐Pi1	  with	  MVV	  and	  CAEV	  strains.	  
3.2.	  Peptide	  ELISA	  
Peptide	  ELISA	  assays	  were	  performed	  on	  a	  panel	  of	  sera	  obtained	  over	  a	  period	  of	  up	  to	  92	  weeks	  p.i.	  from	  
three	  groups	  of	  experimentally	  infected	  sheep:	  group	  A,	  sheep	  1–5,	  infected	  with	  It-­‐561;	  group	  B,	  sheep	  6–
9,	   infected	  with	   It-­‐Pi1	   (Fig.	   2a	   and	   b)	   and	   group	   C,	   four	  mock-­‐infected	   sheep.	   Group	   C	   sheep	   remained	  
seronegative	  throughout	  the	  study	  (data	  not	  shown).	  Group	  A	  sheep	  1–4	  seroconverted	  to	  the	  homologous	  
antigen	  between	  week	  4	  and	  8	  and	  remained	  positive	  throughout	  the	  study.	  Sheep	  1–3	  were	  completely	  
negative	  to	  the	  heterologous	  It-­‐Pi1	  peptide,	  while	  sheep	  4	  raised	  a	  weak	  humoral	  response	  to	  It-­‐Pi1,	  from	  
week	  77	  onwards.	   Sheep	  5	  did	  not	   seroconvert	   and	  was	   the	  only	  one	  negative	   to	  both	   LTR	  and	  Pol	  PCR	  
assays	  performed	  throughout	  the	  study	  to	  confirm	  the	  presence	  of	  virus	  in	  the	  infected	  animals	  (data	  not	  
shown).	   Group	   B	   sheep	   seroconverted	   to	   the	   homologous	   antigen	   between	   week	   3	   and	   8;	   all	   sheep	  
remained	  positive	  until	  the	  end	  of	  the	  experiment,	  with	  high	  absorbance	  values.	  Only	  sheep	  9	  responded	  to	  
the	  heterologous	   antigen	   from	  week	  8	   onwards.	   The	   absorbance,	  which	  was	   about	   twofold	   to	   threefold	  
lower	  than	  for	  the	  homologous	  antigen,	  reached	  a	  peak	  at	  week	  22	  and	  gradually	  decreased	  thereafter,	  to	  
values	  just	  above	  the	  cut-­‐off.	  
	  	  	  	  	  Fig.	  2.	  	  
	  	  	  	  Kinetics	  of	  humoral	  responses	  of	  experimentally	   infected	  sheep	  to	  homologous	  (white	  bars)	  and	  heterologous	  (black	  bars)	  antigen.	  The	  cut-­‐off	  
was	  set	  at	  0.3	  OD.	  *Not	  available.	  (a)	  It-­‐561	  infected	  sheep.	  (b)	  It-­‐Pi1	  infected	  sheep.	  
	  
3.3.	  Kinetics	  of	  antibody	  avidity	  maturation	  
The	  avidity	  maturation	  of	  sera	  was	  assayed	  at	  week	  8	  p.i.,	  corresponding	  to	  the	  first	  antibody	  peak,	  at	  week	  
35	   and	   at	   week	   78.	   The	   results	   obtained	   for	   group	   A	   sheep	   are	   depicted	   in	   Fig.	   3a.	   Sheep	   2,	   3	   and	   4	  
underwent	  a	  marked	  increase	  of	  antibody	  avidity	  over	  the	  period	  analyzed.	  All	  avidity	   indexes	  of	  sheep	  1	  
were	  low;	  therefore	  additional	  time	  points	  were	  analyzed.	  Maturation	  to	  high	  avidity	  was	  detected	  at	  week	  
56,	  followed	  by	  a	  gradual	  decrease	  to	  low	  avidity	  by	  the	  end	  of	  the	  experiment	  (data	  not	  shown.	  Group	  B	  
sheep	  underwent	  a	  marked	  avidity	  maturation,	  reaching	  the	  highest	  values	  at	  week	  35	  p.i.	  (Fig.	  3b).	  
	  
	  	  	  	  Fig.	  3.	  	  
	  	  	  	  Avidity	   maturation	   of	   anti-­‐SU5	   antibody	   taken	   at	   8,	   35,	   78	   weeks	   p.i.	   (a)	   Sheep	   infected	   with	   It-­‐561;	   (b)	   sheep	   infected	   with	   It-­‐Pi1.	   Serum	  
antibodies	  with	  avidity	  index	  values	  lower	  than	  30%	  are	  designated	  low	  avidity	  antibody,	  those	  with	  avidity	  index	  values	  between	  30%	  and	  50%	  are	  
intermediate-­‐avidity	  antibodies,	  and	  those	  with	  values	  higher	  than	  50%	  are	  considered	  high	  avidity	  antibodies.	  
4.	  Discussion	  
Most	  ovine	  isolates	  collected	  in	  Italy	  belong	  to	  the	  CAEV-­‐like	  group	  (Grego	  et	  al.,	  2002)	  and	  co-­‐infection	  of	  
goats	  with	   both	  MVV-­‐	   and	   CAEV-­‐like	   strains	   in	   an	   Italian	   flock	   has	   recently	   been	   reported	   (Pisoni	   et	   al.,	  
2007).	  In	  the	  last	  years	  serological	  assays	  based	  on	  Gag	  antigens	  derived	  from	  Italian	  isolates	  belonging	  to	  
both	   phylogenetic	   groups	   were	   developed	   and	   applied	   in	   field	   conditions:	   the	   response	   obtained	   was	  
largely	   type-­‐specific,	   indicating	   the	   opportunity	   to	   use	   antigens	   representative	   of	   both	   genotypes	   to	  
improve	  the	  sensitivity	  of	   the	  diagnostic	  assays	   (Grego	  et	  al.,	  2002	  and	  Grego	  et	  al.,	  2005).	  Furthermore,	  
when	  sequential	  sera	  collected	  from	  sheep	  experimentally	   infected	  with	  either	   It-­‐561	  or	  with	  It-­‐Pi1,	  were	  
analyzed	   by	   ELISA	   with	   both	   homologous	   and	   heterologous	   CA-­‐MA	   fusion	   proteins,	   the	   homologous	  
antigen	  detected	  infected	  animals	  up	  to	  months	  before	  the	  heterologous	  antigen	  (Lacerenza	  et	  al.,	  2006).	  
In	  this	  study	  the	  same	  panel	  of	  sequential	  sera	  was	  analyzed	  with	  an	  Env	  ELISA	  based	  on	  It-­‐561	  and	  It-­‐Pi1	  
SU5	  peptides.	  Five	  epitopes	  have	  been	  identified	  in	  the	  SU	  subunit	  of	  Env	  (Bertoni	  et	  al.,	  2000	  and	  Valas	  et	  
al.,	  2000).	  SU5	  in	  particular,	  a	  25	  aminoacid	  sequence	  located	  at	  the	  C	  terminus	  of	  SU,	  is	  immunodominant	  
and	   partly	   type-­‐specific:	   it	   carries	   at	   least	   three	   antibody-­‐binding	   sites,	   one	   in	   the	  N-­‐terminal	   conserved	  
region,	  one	  within	  the	  C-­‐terminal	  most	  variable	  domain,	  and	  the	  third	  encompassing	  the	  junction	  between	  
the	  variable	  and	  conserved	  regions	  (Mordasini	  et	  al.,	  2006).	  In	  this	  study,	  two	  env	  gene	  fragments	  encoding	  
respectively	  It-­‐561	  and	  It-­‐Pi1	  SU5,	  were	  sequenced.	  Alignment	  of	  these	  fragments	  with	  sequences	  of	  MVV	  
and	  CAEV	  prototypic	  strains	  of	  worldwide	  origin	  showed	  that	  It-­‐561	  clusters	  with	  the	  MVV	  strains	  and	  It-­‐Pi1	  
is	  phylogenetically	  related	  to	  classical	  CAEV-­‐like	  prototypes.	  The	  SU5	  N-­‐terminal	  amino	  acid	  sequences	  of	  
the	  two	  strains	  share	  extensive	  homology;	  the	  C-­‐terminal	  region	  is	  more	  divergent,	  confirming	  the	  results	  
of	  Mordasini	  et	  al.	   (2006).	  Seroconversion	  kinetics	  of	  groups	  A	  and	  B	  sheep	  were	  similar,	  with	  antibodies	  
being	  mostly	  type-­‐specific.	  The	  few	  broadly	  reacting	  sera	  may	  reflect	  the	  production	  of	  antibodies	  directed	  
to	  the	  constant	  antibody-­‐binding	  site.	  The	  antibody	  levels	  varied	  between	  animals	  and	  for	  the	  same	  animal	  
during	   the	   time	   course	   of	   the	   experiment.	   In	   group	   A,	   the	   first	   antibody	   peak	   was	   followed	   by	   a	   slight	  
decrease	  of	  reactivity	  and	  then	  by	  a	  rise	  to	  three	  to	  fourfold	  higher	  values.	  One	  sheep	  of	  this	  group	  did	  not	  
seroconvert.	   This	   result	   was	  most	   likely	   caused	   by	   a	   technical	   failure	   during	   the	   experimental	   infection,	  
since	  the	  sheep	  was	  repeatedly	  negative	  to	  both	  LTR	  and	  pol	  PCR	  assays	  which	  were	  performed	  on	  blood	  
samples	  of	  the	  experimental	  animals	  to	  confirm	  the	  presence	  of	  viral	  genomes.	  Group	  B	  sheep	  developed	  
immediately	  an	  antibody	  response	  well	  over	  the	  cut-­‐off.	  All	  sera	  underwent	  with	  time	  avidity	  maturation,	  
resulting	   in	   the	  appearance	  of	  high	  affinity	  antibodies,	  although	  with	  different	  kinetics.	   It-­‐Pi1	  sera,	  which	  
developed	  higher	  antibody	  levels	  from	  the	  beginning,	  underwent	  high	  avidity	  maturation	  at	  an	  earlier	  time	  
point	   than	   It-­‐561	  sera.	  Sheep	  1	  showed	  a	  peculiar	  pattern	  of	  avidity	  maturation,	  with	   indexes	  decreasing	  
from	  week	  56	  onwards,	  to	  return	  to	  low	  values	  by	  the	  end	  of	  the	  experiment,	  in	  spite	  of	  a	  persisting	  high	  
antibody	   level.	   The	   reason	   for	   sheep	  1	  behaviour	   is	  unclear;	   the	  genetic	   variability	  of	   SU5	  could	  possibly	  
explain	   the	   disappearance	   of	   the	   high	   affinity	   antibody-­‐producing	   clone(s).	   Alternatively,	   this	   sheep	  may	  
present	  some	  failure	  in	  the	  mechanisms	  that	  underly	  the	  ability	  to	  maintain	  the	  production	  of	  high	  affinity	  
antibodies.	  A	  failure	  of	  T	  helper	  function	  may	  be	  responsible	  for	  the	  loss	  of	  high	  affinity	  antibodies	  as	  well	  
as	  the	  associated	  decay	  of	  the	  antibody	  titer,	  that	  have	  been	  reported	  in	  individuals	  who	  later	  developed	  
AIDS	  (	  Chargelegue	  et	  al.,	  1993,	  Chargelegue	  et	  al.,	  1995	  and	  Thomas	  et	  al.,	  1996).	  SRLV	  infection,	  however,	  
does	  not	  involve	  the	  lymphocyte	  compartment,	  and	  sheep	  1	  antibody	  titer	  does	  not	  decrease,	  therefore	  a	  
different	   mechanism	   may	   be	   responsible.	   A	   comparison	   of	   the	   results	   obtained	   in	   this	   study	   and	   in	  
Lacerenza	  et	  al.	  (2006)	  shows	  that	  both	  CA-­‐MA	  fusion	  antigens	  and	  SU5	  peptides	  detect	  infection	  at	  early	  
stages,	   from	   week	   three	   onwards.	   Furthermore,	   while	   It-­‐561	   drives	   type-­‐specific	   antibody	   response	  
towards	  both	  Gag	  and	  Env	  antigens,	  It-­‐Pi1	  seems	  to	  drive	  production	  of	  type-­‐specific	  antibody	  only	  against	  
SU5.	   In	   fact,	   all	   group	  B	   sheep	   reacted	   against	   the	   heterologous	  Gag	   subunits	   as	  well	   (	   Lacerenza	   et	   al.,	  
2006).	  Since	  the	  humoral	  response	  to	  SU5	  is	  mainly	  directed	  towards	  the	  variable	  antibody-­‐binding	  site,	  a	  
constant	  monitoring	  of	   the	  circulating	  viral	  variants	  will	  be	  necessary	   to	  develop	  a	  panel	  of	  SU5	  peptides	  
representative	  of	  most	  local	  genotypes.	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